INS and early-onset autosomal dominant Alzheimer disease: Nerveless insulin secreted by pancreatic β-cells and transported by cerebrospinal fluid (CSF) can cross the BBB via a saturable receptor-mediated transport, whose efficiency can decrease by pathological conditions, such as obesity, inflammation, and Alzheimer’s disease [2].